Click here to view the Humana Medical Policy Updates Updates » January 2025 Humana Medical…
Blue Cross Idaho Medical Policy Updates – March 2019
Click here to view the Blue Cross Idaho Medical Policy Updates »
March 2019 Blue Cross Idaho Medical Policy Updates:
- Allogeneic Hematopoietic Cell Transplantation for Genetic Diseases and Acquired Anemias
- Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndromes and Myeloproliferative Neoplasms
- Autografts and Allografts in the Treatment of Focal Articular Cartilage Lesions
- Balloon Ostial Dilation for Treatment of Chronic Rhinosinusitis
- Biofeedback as a Treatment of Urinary Incontinence in Adults
- Chronic Intermittent Intravenous Insulin Therapy
- Dopamine Transporter Imaging With Single-Photon Emission Computed Tomography
- Dynamic Posturography
- Experimental / Investigational Services
- Functional Endoscopic Sinus Surgery for Chronic Rhinosinusitis
- General Approach to Genetic Testing
- Genetic Testing for Dilated Cardiomyopathy
- Genetic Testing for Hereditary Pancreatitis
- Genetic Testing for Idiopathic Dilated Cardiomyopathy
- Genetic Testing for PTEN Hamartoma Tumor Syndrome
- Genetic Testing for α-Thalassemia
- Genotype-Guided Tamoxifen Treatment
- Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia
- Hematopoietic Cell Transplantation for Central Nervous System Embryonal Tumors and Ependymoma
- Hematopoietic Cell Transplantation for Chronic Myeloid Leukemia
- Hematopoietic Cell Transplantation for Epithelial Ovarian Cancer
- Hematopoietic Cell Transplantation for Miscellaneous Solid Tumors in Adults
- Hematopoietic Cell Transplantation for Primary Amyloidosis
- Hematopoietic Cell Transplantation For Waldenström Macroglobulinemia
- Hematopoietic Stem-Cell Transplantation in the Treatment of Germ-Cell Tumors
- Negative Pressure Wound Therapy in the Outpatient Setting
- Next Generation Sequencing for the Assessment of Measurable Residual Disease
- Orthopedic Applications of Stem Cell Therapy (Including Allografts and Bone Substitutes Used With Autologous Bone Marrow)
- Stem Cell Therapy for Peripheral Arterial Disease
- Temporomandibular Joint Disorder
- Transtympanic Micropressure Applications as a Treatment of Meniere Disease
- Treatment of Hereditary Transthyretin-Mediated Amyloidosis in Adult Patients
- Treatment of Varicose Veins/Venous Insufficiency
- Treatment of Varicose Veins/Venous Insufficiency
- Vestibular Function Testing
Click here to view the Blue Cross Idaho Medical Policy Updates »
Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.
Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!
Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.
Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.